Minerva Neurosciences, Inc. Proceeds from Issuance of Private Placement
Minerva Neurosciences, Inc. (NERV) reported Proceeds from Issuance of Private Placement of $80.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2026-03-11
- Minerva Neurosciences, Inc. proceeds from issuance of private placement for the quarter ending 2023-12-31 was $0.00.
- Minerva Neurosciences, Inc. proceeds from issuance of private placement for the quarter ending 2023-09-30 was $0.00.
- Minerva Neurosciences, Inc. proceeds from issuance of private placement for the quarter ending 2016-12-31 was $0.00.
- Minerva Neurosciences, Inc. proceeds from issuance of private placement for the quarter ending 2016-09-30 was $0.00.
- Minerva Neurosciences, Inc. proceeds from issuance of private placement for fiscal 2025 was $80.00M.
- Minerva Neurosciences, Inc. proceeds from issuance of private placement for fiscal 2023 was $20.00M.
- Minerva Neurosciences, Inc. proceeds from issuance of private placement for fiscal 2016 was $1000.00K, a 96.77% decline from fiscal 2015.
- Minerva Neurosciences, Inc. proceeds from issuance of private placement for fiscal 2015 was $31.00M, a 30.77% increase from fiscal 2014.
| Period end | Proceeds from Issuance of Private Placement 0 month | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $80.00M 10-K · filed 2026-03-11 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $20.00M 10-K · filed 2025-02-25 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $20.00M 10-Q · filed 2024-11-05 | |||
| 2023-06-30 | $20.00M 10-Q · filed 2024-08-06 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $0.00 derived: sum of 2 quarters · filed 2018-03-12 | $0.00 derived: sum of 3 quarters · filed 2018-03-12 | $1000.00K 10-K · filed 2018-03-12 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $0.00 derived: sum of 2 quarters · filed 2017-11-06 | $1000.00K 10-Q · filed 2017-11-06 | $1000.00K derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $1000.00K 10-Q · filed 2017-08-03 | $1000.00K derived: sum of 3 quarters · filed 2018-03-12 | $1000.00K derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-03-31 | $1000.00K 10-Q · filed 2017-05-04 | $1000.00K derived: sum of 2 quarters · filed 2018-03-12 | $1000.00K derived: sum of 3 quarters · filed 2018-03-12 | $1000.00K derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-03-17 | $1.00M 10-K · filed 2018-03-12 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $0.00 derived: sum of 2 quarters · filed 2018-03-12 | $0.00 derived: sum of 3 quarters · filed 2018-03-12 | $31.00M 10-K · filed 2018-03-12 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $31.00M 10-Q · filed 2016-11-03 | $31.00M derived: sum of 4 quarters · filed 2017-03-13 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $31.00M 10-Q · filed 2016-08-04 | $31.00M derived: sum of 3 quarters · filed 2017-03-13 | ||
| 2015-03-31 | $31.00M 10-Q · filed 2016-05-03 | $31.00M derived: sum of 2 quarters · filed 2017-03-13 | |||
| 2015-03-18 | $31.00M 10-K · filed 2018-03-12 | ||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $23.71M 10-K · filed 2017-03-13 | |||
| 2014-09-30 | $23.71M 10-Q · filed 2015-11-05 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $1.85M 10-K · filed 2015-03-26 | |||
| 2013-09-30 | $1.85M 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |